Methods and compositions for the determination of protein function and identification of modulators thereof
CA 2335392 A1 · Owner: Small Molecule Therapeutics, Inc. · Inventors: Khazak, Vladimir; Menzel, Rolf
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides libraries of tag dominant-negative elements (TDNE) and methods enabling the identification of specific TDNEs that act as dominant-negative elements on a target protein of interest. The present invention further relates to the use of such TDNEs and dominant-negative elements for the identification of protein-protein interactions and the , determination of a target protein's biological activity and function. Furthermore, the present invention relates to the development of means including small molecule compounds, for disrupting the target protein's biological function and activity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 23, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 23, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 23, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.